about us
investors
products
technologies
clinical trials
news
careers
contact
site map
Corporate Info
Corporate Governance
Company News and Events
Financial Info
Stock Info
Shareholder Services

SEC Filings




  
Add to Briefcase = Add Filing to Briefcase
Filing Description Date Filed Sorted Descending Size  
3 neumayer matthew paul 11-06-09 17.0 KB Add to Briefcase
10-Q quarterly report 11-06-09 329.2 KB Add to Briefcase
8-K current report 11-04-09 88.7 KB Add to Briefcase
8-K current report 09-11-09 68.3 KB Add to Briefcase
8-K current report 09-08-09 54.0 KB Add to Briefcase
10-Q quarterly report 08-07-09 335.9 KB Add to Briefcase
8-K current report 08-06-09 84.8 KB Add to Briefcase
4 mills, c randal 08-05-09 19.4 KB Add to Briefcase
8-K current report 07-07-09 20.5 KB Add to Briefcase
CT ORDER confidential treatment order 07-01-09 12.9 KB Add to Briefcase
8-K current report 06-25-09 48.7 KB Add to Briefcase
CT ORDER confidential treatment order 05-21-09 13.0 KB Add to Briefcase
4 debrabandere, lode 05-18-09 19.7 KB Add to Briefcase
10-Q quarterly report 05-11-09 396.8 KB Add to Briefcase
8-K current report 05-07-09 80.1 KB Add to Briefcase
DEF 14A definitive proxy statement 04-24-09 275.8 KB Add to Briefcase
8-K current report 04-21-09 28.7 KB Add to Briefcase
8-K current report 03-30-09 33.4 KB Add to Briefcase
8-K current report 03-27-09 23.1 KB Add to Briefcase
10-K annual report 03-16-09 1.4 MB Add to Briefcase
Showing 1-20 of 180 filings Page: 1 2 3 4 5 6 7 8 9  See Next 20

Stock Information

OSIR - (NASDAQ)
$6.57           + 0.09
11-20-09       4:11 PM ET
Quotes delayed at least 20 minutes. Information provided by eSignal.

Shareholder Tools

© 2009 Osiris Therapeutics, Inc.
7015 Albert Einstein Drive · Columbia, MD · 21046 · p(443)545-1800 · f(443)545-1701 osiris@osiris.com
Legal Notice